Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab.
Martens A, Wistuba-Hamprecht K, Yuan J, Postow MA, Wong P, Capone M, Madonna G, Khammari A, Schilling B, Sucker A, Schadendorf D, Martus P, Dreno B, Ascierto PA, Wolchok JD, Pawelec G, Garbe C, Weide B. Martens A, et al. Among authors: garbe c. Clin Cancer Res. 2016 Oct 1;22(19):4848-4858. doi: 10.1158/1078-0432.CCR-16-0249. Epub 2016 May 11. Clin Cancer Res. 2016. PMID: 27169993 Free PMC article.
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK, Buettner PG, Leiter U, Garbe C; Central Malignant Melanoma Registry of the German Dermatological Society. Eigentler TK, et al. Among authors: garbe c. J Clin Oncol. 2004 Nov 1;22(21):4376-83. doi: 10.1200/JCO.2004.03.075. J Clin Oncol. 2004. PMID: 15514379
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
Kaufmann R, Spieth K, Leiter U, Mauch C, von den Driesch P, Vogt T, Linse R, Tilgen W, Schadendorf D, Becker JC, Sebastian G, Krengel S, Kretschmer L, Garbe C, Dummer R; Dermatologic Cooperative Oncology Group. Kaufmann R, et al. Among authors: garbe c. J Clin Oncol. 2005 Dec 10;23(35):9001-7. doi: 10.1200/JCO.2005.01.1551. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260697 Clinical Trial.
[Brief guidelines: malignant melanoma of the skin].
Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R. Garbe C, et al. J Dtsch Dermatol Ges. 2006 Apr;4(4):344-9. doi: 10.1111/j.1610-0387.2006.05891.x. J Dtsch Dermatol Ges. 2006. PMID: 16638065 Review. German. No abstract available.
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma.
Eigentler TK, Kamin A, Weide BM, Breuninger H, Caroli UM, Möhrle M, Radny P, Garbe C. Eigentler TK, et al. Among authors: garbe c. J Am Acad Dermatol. 2007 Oct;57(4):616-21. doi: 10.1016/j.jaad.2007.05.022. Epub 2007 Jul 3. J Am Acad Dermatol. 2007. PMID: 17610993 Clinical Trial.
New promises in the adjuvant, and palliative treatment of melanoma.
Hauschild A, Schadendorf D, Garbe C, Ugurel S, Kähler KC. Hauschild A, et al. Among authors: garbe c. Cancer Treat Res. 2007;135:277-92. doi: 10.1007/978-0-387-69219-7_20. Cancer Treat Res. 2007. PMID: 17953423 Review. No abstract available.
799 results